A detailed history of Cibc Private Wealth Group, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,439 shares of TGTX stock, worth $50,465. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,439
Previous 1,689 14.8%
Holding current value
$50,465
Previous $30,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$17.21 - $25.28 $4,302 - $6,320
-250 Reduced 14.8%
1,439 $33,000
Q2 2024

Aug 09, 2024

BUY
$13.32 - $19.19 $13,320 - $19,190
1,000 Added 145.14%
1,689 $30,000
Q1 2024

May 10, 2024

BUY
$13.02 - $21.3 $8,970 - $14,675
689 New
689 $10,000
Q3 2018

Nov 14, 2018

SELL
$5.15 - $14.0 $9,270 - $25,200
-1,800 Closed
0 $0
Q2 2018

Aug 02, 2018

BUY
$12.5 - $15.0 $15,000 - $18,000
1,200 Added 200.0%
1,800 $24,000
Q1 2018

May 17, 2018

BUY
$8.7 - $16.8 $5,220 - $10,080
600 New
600 $9,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $5.09B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Cibc Private Wealth Group, LLC Portfolio

Follow Cibc Private Wealth Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.